In contrast, the intranasal administration of exogenous Sema3E reduced these pathological effects [14,22,23,26], hence underscoring the essential role of the Sema3E-plexinD1 axis in maintaining homeostasis in allergic asthma [14]. The gene discussed is SEMA3E; the disease is allergic asthma.